ArticleTherapeutic advances in neurological disorders2020

PF-06649751 efficacy and safety in early Parkinson's disease: a randomized, placebo-controlled trial.

Robert Riesenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.